Advanced Search
Contact | Corporate | Help

Letrozole and Herceptin in Her2neu Positive, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, Metastatic Breast Cancer

Sponsors:
  • Duke University
  • Genentech
  • Novartis
Phases:
  • Phase II
IndicationsAcronym:
  • Metastatic Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Letrozole
  • Drug: Trastuzumab
Enrollment:
35

Additional information about NCT00134680.


SourceSolution © 2008-2012